- Company Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
Biohaven Pharmaceutical Holding
Company Profile
Quarter (USD) | Jun 22 | Mar 22 | Dec 21 | Sep 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 21 | Dec 20 | Dec 19 | Dec 18 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 236.56 mm | 236.56 mm | 236.56 mm | 236.56 mm | 236.56 mm | 236.56 mm |
Cash burn (monthly) | (no burn) | 5.97 mm | 147.27 mm | 75.78 mm | (no burn) | 35.01 mm |
Cash used (since last report) | n/a | 177.79 mm | 4.39 bn | 2.26 bn | n/a | 1.04 bn |
Cash remaining | n/a | 58.76 mm | -4.15 bn | -2.02 bn | n/a | -806.85 mm |
Runway (months of cash) | n/a | 9.8 | -28.2 | -26.7 | n/a | -23.0 |
13F holders | Current |
---|---|
Total holders | 1 |
Opened positions | 0 |
Closed positions | 1 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 30.00 |
Total calls | 0.00 |
Total put/call ratio | Infinity |
Largest owners | Shares | Value |
---|---|---|
FNY Investment Advisers | 0.00 | $0.00 |